PULSE BIOSCIENCES, INC. — Director's Dealing 2017

May 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-05-09

Reporting Person: DUGGAN ROBERT W (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-09	Common Stock	P	1300	$19.428	Acquired	2984227	Direct
2017-05-09	Common Stock	P	5000	$20.072	Acquired	2989227	Direct
2017-05-09	Common Stock	P	19489	$21.466	Acquired	3008716	Direct
2017-05-11	Common Stock	P	10100	$20.549	Acquired	3018816	Direct
2017-05-11	Common Stock	P	7500	$21.517	Acquired	3026316	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	35000	Indirect

Footnotes

F1: This is the weighted average purchase price of the shares, which ranged from $18.98 to $19.95 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F2: This is the weighted average purchase price of the shares, which ranged from $21.153 to $21.75 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F3: This is the weighted average purchase price of the shares, which ranged from $20.451 to $20.60 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F4: This is the weighted average purchase price of the shares, which ranged from $21.47 to $21.737 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F5: Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary.